Its very common for pharmaceutical companies to collect genetic data on their participants, she said
Overall, the selected trials had a low to moderate risk of bias
She is ecstatic and her vitality/energy/mood and outlook on life have all improved. Stanford sees similar results in her clinic, with patients able to reduce insulin or come off anti-hypertensive drugs altogether
This is not just about looking cute in a bikini somewhere, she says
For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM, that explain poor responders to their medications. For now, the mechanism driving GLP-1 resistance remains unresolved, but it is likely complex and multifactorial, Gloyn said
I had anticipated that many patients would not want to start an injectable medication, but this has not been a barrier for most of my patients, and the availability of a medication that can be injected once weekly has made it possible for more patients to agree to try, she says
